Dopamine treatment does not need speed recovery of newborns from transient tachypnea

Abstract

AbstractTransient tachypnea of the newborn (TTN) results from inadequate neonatal lung fluid clearance. Low-dose dopamine induces natriuresis in the kidneys and it has been assumed that, at this low dosage, dopamine increases renal perfusion in critically ill patients. Medium doses have positive inotropic and chronotropic effects via increased β-receptor activation. Recent studies have demonstrated that dopamine stimulates the clearance of pulmonary edema. Furthermore, β-adrenergic agonists regulate NaA prospective controlled study examined 60 infants with TTN older than 34 weeks of gestation who required at least 24 h of OThe requirement for mechanical ventilation, and durations of nCPAP, oxygen requirement, and hospitalization did not differ significantly among the three groups (P=0.54, 0.16 and 0.11, respectively).Dopamine treatment in low-moderate doses does not improve the outcome in TTN. Thus, further studies in this area are needed.